2016 Q1 Form 10-K Financial Statement

#000114420416091312 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015
Revenue $124.7K $20.00K $338.9K
YoY Change 23.42% -91.67% -34.43%
Cost Of Revenue $294.8K $50.00K $1.225M
YoY Change -36.21% -91.07% 2.23%
Gross Profit -$170.1K -$20.00K -$885.8K
YoY Change -52.89% -93.75% 31.3%
Gross Profit Margin -136.41% -100.0% -261.4%
Selling, General & Admin $594.4K $610.0K $5.518M
YoY Change -75.11% -76.26% -30.96%
% of Gross Profit
Research & Development $85.62K $80.00K $375.8K
YoY Change -39.83% -63.64% -38.42%
% of Gross Profit
Depreciation & Amortization $0.00 $130.0K $651.00
YoY Change -100.0% 85.71% -79.63%
% of Gross Profit
Operating Expenses $818.5K $830.0K $6.428M
YoY Change -69.27% -70.88% -28.73%
Operating Profit -$988.7K -$850.0K -$7.314M
YoY Change -67.32% -73.19% -24.55%
Interest Expense -$110.2K $100.0K $4.280K
YoY Change -3645.7%
% of Operating Profit
Other Income/Expense, Net -$3.522M $0.00 $104.8K
YoY Change -113464.15% -284.59%
Pretax Income -$4.510M -$750.0K -$7.210M
YoY Change 49.34% -76.71% -26.05%
Income Tax
% Of Pretax Income
Net Earnings -$4.511M -$750.0K -$7.209M
YoY Change 49.28% -76.71% -26.07%
Net Earnings / Revenue -3617.32% -3750.0% -2127.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.379M -$229.4K -$2.239M
COMMON SHARES
Basic Shares Outstanding 81.72M shares 81.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.130M $1.740M $1.740M
YoY Change 37.8% 0.0% 0.0%
Cash & Equivalents $1.080M $1.687M
Short-Term Investments $50.00K $50.00K $50.00K
Other Short-Term Assets $40.00K $40.00K $40.00K
YoY Change -71.43% -55.56% -55.56%
Inventory
Prepaid Expenses
Receivables $19.28K $22.74K $20.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.190M $1.805M $1.800M
YoY Change 19.0% -44.87% -44.95%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00
YoY Change -100.0%
Goodwill $700.5K $700.5K
YoY Change 0.0%
Intangibles $2.738M $2.841M
YoY Change -8.28%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.444M $3.541M $3.550M
YoY Change -6.68% -6.77% -6.58%
TOTAL ASSETS
Total Short-Term Assets $1.190M $1.805M $1.800M
Total Long-Term Assets $3.444M $3.541M $3.550M
Total Assets $4.634M $5.346M $5.350M
YoY Change -1.2% -24.41% -24.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $270.0K $210.0K $210.0K
YoY Change -47.06% -73.08% -73.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $20.00K $20.00K $20.00K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $4.434M $891.2K $890.0K
YoY Change 691.7% -22.95% -23.28%
LONG-TERM LIABILITIES
Long-Term Debt $1.960M $1.920M $1.920M
YoY Change 4800.0% 3740.0% 3740.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.960M $1.923M $1.920M
YoY Change 4800.0% 3613.32% 3740.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.434M $891.2K $890.0K
Total Long-Term Liabilities $1.960M $1.923M $1.920M
Total Liabilities $6.397M $2.815M $2.810M
YoY Change 948.71% 132.9% 132.23%
SHAREHOLDERS EQUITY
Retained Earnings -$28.75M -$24.24M
YoY Change 42.33%
Common Stock $817.00 $817.00
YoY Change 5.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $623.0K $623.0K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$1.763M $2.532M $2.530M
YoY Change
Total Liabilities & Shareholders Equity $4.634M $5.346M $5.350M
YoY Change -1.2% -24.41% -24.33%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$4.511M -$750.0K -$7.209M
YoY Change 49.28% -76.71% -26.07%
Depreciation, Depletion And Amortization $0.00 $130.0K $651.00
YoY Change -100.0% 85.71% -79.63%
Cash From Operating Activities -$560.0K -$670.0K -$5.470M
YoY Change -76.86% -67.16% -5.69%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$190.0K -$280.0K
YoY Change -100.0% -258.33% -36.36%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$40.00K -$190.0K -$280.0K
YoY Change 33.33% -371.43% -42.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $325.0K
YoY Change -100.0% -87.89%
Debt Paid & Issued, Net $28.00K
YoY Change -84.27%
Cash From Financing Activities -10.00K 2.500M 5.770M
YoY Change -100.65% 67.79% -5.56%
NET CHANGE
Cash From Operating Activities -560.0K -670.0K -5.470M
Cash From Investing Activities -40.00K -190.0K -280.0K
Cash From Financing Activities -10.00K 2.500M 5.770M
Net Change In Cash -610.0K 1.640M 20.00K
YoY Change -32.97% -441.67% -111.11%
FREE CASH FLOW
Cash From Operating Activities -$560.0K -$670.0K -$5.470M
Capital Expenditures $0.00 -$190.0K -$280.0K
Free Cash Flow -$560.0K -$480.0K -$5.190M
YoY Change -76.57% -77.78% -3.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q2 dei Entity Public Float
EntityPublicFloat
8756678 USD
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Trading Symbol
TradingSymbol
AEYE
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81717154 shares
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
90688 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
651 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2840856 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3097293 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
516807 USD
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
338863 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41388 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
1804986 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
3274065 USD
CY2015Q4 us-gaap Goodwill
Goodwill
700528 USD
CY2014Q4 us-gaap Goodwill
Goodwill
700528 USD
CY2015Q4 us-gaap Assets
Assets
5346370 USD
CY2014Q4 us-gaap Assets
Assets
7072537 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
213620 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
779891 USD
CY2015Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
0 USD
CY2014Q4 us-gaap Billings In Excess Of Cost Current
BillingsInExcessOfCostCurrent
123908 USD
CY2015Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
24000 USD
CY2014Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
24000 USD
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
153474 USD
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
228983 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
891245 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1156782 USD
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
1923499 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
51800 USD
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1923499 USD
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
51800 USD
CY2015Q4 us-gaap Liabilities
Liabilities
2814744 USD
CY2014Q4 us-gaap Liabilities
Liabilities
1208582 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
2 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
817 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
778 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
623000 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
623000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27393238 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23516463 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24239431 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17030286 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
2531626 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
5863955 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5346370 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7072537 USD
CY2015Q4 us-gaap Cash
Cash
1687257 USD
CY2014Q4 us-gaap Cash
Cash
1672901 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22741 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
261676 USD
CY2015Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2014Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
10000 USD
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3600 USD
CY2014Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13800 USD
CY2015Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
50000 USD
CY2014Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
50000 USD
CY2015Q4 aeye Subscription Receivable
SubscriptionReceivable
0 USD
CY2014Q4 aeye Subscription Receivable
SubscriptionReceivable
1175000 USD
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
1224652 USD
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
1197936 USD
CY2015 us-gaap Gross Profit
GrossProfit
-885789 USD
CY2014 us-gaap Gross Profit
GrossProfit
-674629 USD
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
884440 USD
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1537732 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
384875 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
375817 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
610329 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4633702 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6455327 USD
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
534220 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
416009 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
6428179 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
9019397 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-7313968 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-9694026 USD
CY2015 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
534220 USD
CY2014 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
416009 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1075749 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1844009 USD
CY2015 aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
682126 USD
CY2014 aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
918315 USD
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
26992 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1155 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-238935 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-139301 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-10000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-72250 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-566272 USD
CY2015 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
-123908 USD
CY2014 us-gaap Increase Decrease In Billing In Excess Of Cost Of Earnings
IncreaseDecreaseInBillingInExcessOfCostOfEarnings
123908 USD
CY2015 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-75509 USD
CY2014 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-14441 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5474454 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5801600 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-277131 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-486162 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
325000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2682689 USD
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1750000 USD
CY2014 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2015 aeye Increase Decrease In Stock Subscription Receivable
IncreaseDecreaseInStockSubscriptionReceivable
-1175000 USD
CY2014 aeye Increase Decrease In Stock Subscription Receivable
IncreaseDecreaseInStockSubscriptionReceivable
0 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5765941 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6113659 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14356 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-174103 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1672901 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1847004 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1687257 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-7209145 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-9750813 USD
CY2015 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-10200 USD
CY2014 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-10200 USD
CY2015 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
35000 USD
CY2015 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
43941 USD
CY2014 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3643970 USD
CY2015 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 USD
CY2014 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
6500 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
60790 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2015Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2014Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
175000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
175000 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81717154 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77817861 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77817861 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81717154 shares
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3814 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2015 aeye Loss On Conversion Of Accounts Receivable
LossOnConversionOfAccountsReceivable
0 USD
CY2014 aeye Loss On Conversion Of Accounts Receivable
LossOnConversionOfAccountsReceivable
36000 USD
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> The preparation of financial statements, in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160; Actual results could differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Fiscal Period
FiscalPeriod
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u>Fiscal Year End</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> The Company has a fiscal year ending on December&#160;31.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
439361 USD
CY2015 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
233442 USD
CY2014 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
388125 USD
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
28000 USD
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
178000 USD
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2500000 USD
CY2014 aeye Debt Discount On Warrants Issued With Debt
DebtDiscountOnWarrantsIssuedWithDebt
0 USD
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2015 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
0 USD
CY2014 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
108320 USD
CY2015 aeye Loss On Conversion Of Accounts Receivable To Marketable Securities
LossOnConversionOfAccountsReceivableToMarketableSecurities
0 USD
CY2014 aeye Loss On Conversion Of Accounts Receivable To Marketable Securities
LossOnConversionOfAccountsReceivableToMarketableSecurities
36000 USD
CY2014 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
90688 USD
CY2015 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-49300 USD
CY2015 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
-60790 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
43689 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
48037 USD
CY2015 aeye Payments To Acquire Cost Method Investments
PaymentsToAcquireCostMethodInvestments
0 USD
CY2014 aeye Payments To Acquire Cost Method Investments
PaymentsToAcquireCostMethodInvestments
50000 USD
CY2015 aeye Debt Discount On Warrants Issued With Debt
DebtDiscountOnWarrantsIssuedWithDebt
627293 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25478 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24827 USD
CY2015 us-gaap Depreciation
Depreciation
651 USD
CY2014 us-gaap Depreciation
Depreciation
3196 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6373434 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4983000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6373434 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4983000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
14657000 USD
CY2015Q4 aeye Number Of Patents Issued
NumberOfPatentsIssued
6 item
CY2015Q4 aeye Number Of Pending Patents
NumberOfPendingPatents
2 item
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19675 USD
CY2015 aeye Common Stock Issuance Price Per Share
CommonStockIssuancePricePerShare
0.10
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.10
CY2015 us-gaap Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
1.02 pure
CY2015 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
187932 USD
CY2015Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1899699 USD
CY2014Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
314485 USD
CY2014Q1 aeye Common Stock Shares Authorized Before Amendment
CommonStockSharesAuthorizedBeforeAmendment
100000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49496 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
100000 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
100000 shares
CY2014Q1 aeye Common Stock Issuance Costs
CommonStockIssuanceCosts
28500 USD
CY2014Q1 aeye Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1300000 shares
CY2014Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
13000 USD
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1071916 shares
CY2014Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
354835 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
302230 USD
CY2014Q1 aeye Escrow Shares
EscrowShares
250000 shares
CY2014Q2 aeye Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
50000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34459 shares
CY2014Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
75000 shares
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
515000 shares
CY2014Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
382300 USD
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
20000 shares
CY2014Q3 aeye Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
20000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2014Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
10000 USD
CY2014Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
195000 shares
CY2014Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
119500 USD
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9115 shares
CY2014Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30000 shares
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4375 shares
CY2014Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
37314 shares
CY2014Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
19888 USD
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
331804 shares
CY2014Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
119449 USD
CY2015Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 USD
CY2014Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 USD
CY2015Q1 aeye Proceeds From Units Sold To Accredited Investors
ProceedsFromUnitsSoldToAccreditedInvestors
325000 USD
CY2015Q2 us-gaap Shares Issued
SharesIssued
175000 shares
CY2015Q2 aeye Private Placement Cost For Units Sold To Accredited Investors
PrivatePlacementCostForUnitsSoldToAccreditedInvestors
1750000 USD
CY2015Q4 us-gaap Share Price
SharePrice
0.0306
CY2015 aeye Adjustments To Additional Paid In Capital Warrant Options And Psu Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantOptionsAndPsuIssuedForServices
1075749 USD
CY2014 aeye Adjustments To Additional Paid In Capital Warrant Options And Psu Issued For Services
AdjustmentsToAdditionalPaidInCapitalWarrantOptionsAndPsuIssuedForServices
1844009 USD
CY2015Q4 us-gaap Shares Issued
SharesIssued
175000 shares
CY2015 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.05 pure
CY2015Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.1754
CY2014Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
CY2015 aeye Lease Rent Per Month
LeaseRentPerMonth
4724 USD
CY2015Q4 aeye Area Of Principal Executive Offices
AreaOfPrincipalExecutiveOffices
2362 sqft
CY2015Q2 us-gaap Share Price
SharePrice
10.00
CY2015Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.1754
CY2015 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
187932 USD
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 USD
CY2015 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-72443 USD
CY2014 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10587 USD
CY2015 us-gaap Interest Expense
InterestExpense
4280 USD
CY2014 us-gaap Interest Expense
InterestExpense
0 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
104823 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-56787 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
80445509 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61962359 shares
CY2014 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
0 USD
CY2015 aeye Value Of Warrants Issuedcancellation Of Common Stock
ValueOfWarrantsIssuedcancellationOfCommonStock
1 USD
CY2014 aeye Warrants Issued1
WarrantsIssued1
21514 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9750813 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
5329271 USD
CY2015 us-gaap Interest Paid
InterestPaid
4567 USD
CY2014 us-gaap Interest Paid
InterestPaid
11301 USD
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
18745343 USD
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
439361 USD
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2015Q4 aeye Working Capital
WorkingCapital
913741 USD
CY2015 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
594641 USD
CY2014 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2015 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
58733 USD
CY2014 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
0 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7862519 USD
CY2014 aeye Stock Issued During Period Value For Cash
StockIssuedDuringPeriodValueForCash
3857689 USD
CY2014 aeye Stock Issued During Period Value For Exercise Of Warrants
StockIssuedDuringPeriodValueForExerciseOfWarrants
3643970 USD
CY2015 us-gaap Revenue Recognition Long Term Contracts
RevenueRecognitionLongTermContracts
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Billings in Excess of Revenues</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company applies percentage of completion accounting to long term contracts. Revenue is recognized as a portion of the contract term as services are delivered, and differed revenue is recorded, only upon the receipt of cash. Timing and accounts affected by the respective journal entry are triggered when payment is received and applied to invoices in accounts receivable. There were no long-term contracts in process as of December 31, 2015.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
918315 USD
CY2014 aeye Cashless Exercise Of Options And Warrants
CashlessExerciseOfOptionsAndWarrants
0 USD
CY2014 aeye Adjustments To Additional Paid In Capital Warrant Issued For Conversion Of Accrued Salary
AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForConversionOfAccruedSalary
21514 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
1750000 USD
CY2015 aeye Stock Issued During Period Value For Cash
StockIssuedDuringPeriodValueForCash
325000 USD
CY2015 aeye Stock Issued During Period Value For Exercise Of Warrants
StockIssuedDuringPeriodValueForExerciseOfWarrants
43941 USD
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
682126 USD
CY2015 aeye Warrants Issued For Cancellation Of Common Stock
WarrantsIssuedForCancellationOfCommonStock
0 USD
CY2015 aeye Non Cash Or Part Non Cash Stock Issued For Subscription Receivable
NonCashOrPartNonCashStockIssuedForSubscriptionReceivable
0 USD
CY2014 aeye Non Cash Or Part Non Cash Stock Issued For Subscription Receivable
NonCashOrPartNonCashStockIssuedForSubscriptionReceivable
1175000 USD
CY2015 aeye Non Cash Or Part Noncash Conversion Of Accounts Receivable To Marketable Securities
NonCashOrPartNoncashConversionOfAccountsReceivableToMarketableSecurities
0 USD
CY2014 aeye Non Cash Or Part Noncash Conversion Of Accounts Receivable To Marketable Securities
NonCashOrPartNoncashConversionOfAccountsReceivableToMarketableSecurities
60000 USD
CY2015 aeye Noncash Or Part Noncash Stock Issued For Exercise Of Options And Warrants
NoncashOrPartNoncashStockIssuedForExerciseOfOptionsAndWarrants
0 USD
CY2014 aeye Noncash Or Part Noncash Stock Issued For Exercise Of Options And Warrants
NoncashOrPartNoncashStockIssuedForExerciseOfOptionsAndWarrants
1 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18770591 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
9506205 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
28913020 shares
CY2014 aeye Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod
11748807 shares
CY2015 aeye Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod
109855 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
3054545 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
16527989 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
42276609 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.35
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.51
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.11
CY2014 aeye Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
0.36
CY2015 aeye Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
0.40
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.46
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.22
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.43
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P4Y7M13D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y8M8D
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P4Y1M24D
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
309821 USD
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1167 USD
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
416000 USD
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2500000 USD
CY2015Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
627293 USD
CY2014 aeye Value Of Warrants Issuedcancellation Of Common Stock
ValueOfWarrantsIssuedcancellationOfCommonStock
0 USD
CY2015 aeye Warrants Issued1
WarrantsIssued1
0 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1435781 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
902212 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3097293 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2840856 USD
CY2015 us-gaap Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability
LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability
100000 USD
CY2015Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
513003 USD
CY2015 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2300000 shares

Files In Submission

Name View Source Status
0001144204-16-091312-index-headers.html Edgar Link pending
0001144204-16-091312-index.html Edgar Link pending
0001144204-16-091312.txt Edgar Link pending
0001144204-16-091312-xbrl.zip Edgar Link pending
aeye-20151231.xml Edgar Link completed
aeye-20151231.xsd Edgar Link pending
aeye-20151231_cal.xml Edgar Link unprocessable
aeye-20151231_def.xml Edgar Link unprocessable
aeye-20151231_lab.xml Edgar Link unprocessable
aeye-20151231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogo.jpg Edgar Link pending
v434574_10k.htm Edgar Link pending
v434574_ex21-1.htm Edgar Link pending
v434574_ex31-1.htm Edgar Link pending
v434574_ex31-2.htm Edgar Link pending
v434574_ex32-1.htm Edgar Link pending
v434574_ex32-2.htm Edgar Link pending